PM360 2021 Trailblazer Awards Consumer Website/Online Initiative Gold Winner Kala Pharmaceuticals and QBFox Healthcomm

EYSUVIS, “MYEYSUVIS” (Kala Pharmaceuticals, QBFox Healthcomm)

The innovative Dry Eye Disease (DED) campaign from EYSUVIS centered around “Droppy,” a stylized blue eyedrop character (based on the EYSUVIS logo) who delivers knowledgeable and reassuring information to patients. As well, “Droppy” shows how EYSUVIS can provide the kind of relief these patients have never seen or experienced before. The character confidently teaches patients about DED and gives them the tools and language to speak with their eye care providers (ECPs) about treatment.

Although the campaign kicked off in the height of the pandemic, more patients than expected are visiting the site, downloading resources, and visiting their ECPs armed with powerful information.

Ads

You May Also Like

ELITE 2021 Marketing Team XYWAV Launch Team

XYWAV Launch Team Jazz Pharmaceuticals Agency Partners: Scout Marketing, Healix, Hoverstate, and MEI Jazz ...

ELITE 2021 Creative Director Kevin Millar of INVIVO

Kevin Millar Senior Vice President, Creative & Medical Science INVIVO, a Red Nucleus Company ...

Two Key Questions About Data Analytics in 2021

PM360 asked experts in data analytics how the digital transformation of healthcare is changing ...